Correlation Between Nuvation Bio and Achilles Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nuvation Bio and Achilles Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvation Bio and Achilles Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvation Bio and Achilles Therapeutics PLC, you can compare the effects of market volatilities on Nuvation Bio and Achilles Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvation Bio with a short position of Achilles Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvation Bio and Achilles Therapeutics.

Diversification Opportunities for Nuvation Bio and Achilles Therapeutics

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between Nuvation and Achilles is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Nuvation Bio and Achilles Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Achilles Therapeutics PLC and Nuvation Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvation Bio are associated (or correlated) with Achilles Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Achilles Therapeutics PLC has no effect on the direction of Nuvation Bio i.e., Nuvation Bio and Achilles Therapeutics go up and down completely randomly.

Pair Corralation between Nuvation Bio and Achilles Therapeutics

Given the investment horizon of 90 days Nuvation Bio is expected to under-perform the Achilles Therapeutics. In addition to that, Nuvation Bio is 1.15 times more volatile than Achilles Therapeutics PLC. It trades about -0.02 of its total potential returns per unit of risk. Achilles Therapeutics PLC is currently generating about 0.13 per unit of volatility. If you would invest  71.00  in Achilles Therapeutics PLC on November 2, 2024 and sell it today you would earn a total of  41.00  from holding Achilles Therapeutics PLC or generate 57.75% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Nuvation Bio  vs.  Achilles Therapeutics PLC

 Performance 
       Timeline  
Nuvation Bio 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Nuvation Bio are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nuvation Bio may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Achilles Therapeutics PLC 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Achilles Therapeutics PLC are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical indicators, Achilles Therapeutics may actually be approaching a critical reversion point that can send shares even higher in March 2025.

Nuvation Bio and Achilles Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nuvation Bio and Achilles Therapeutics

The main advantage of trading using opposite Nuvation Bio and Achilles Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvation Bio position performs unexpectedly, Achilles Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Achilles Therapeutics will offset losses from the drop in Achilles Therapeutics' long position.
The idea behind Nuvation Bio and Achilles Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Commodity Directory
Find actively traded commodities issued by global exchanges
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.